Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001546253 | SCV001765744 | uncertain significance | not provided | 2021-05-11 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004039272 | SCV003588561 | uncertain significance | Cardiovascular phenotype | 2021-12-02 | criteria provided, single submitter | clinical testing | The c.2651C>T (p.P884L) alteration is located in exon 1 (coding exon 1) of the ZNF469 gene. This alteration results from a C to T substitution at nucleotide position 2651, causing the proline (P) at amino acid position 884 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |